Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2026 · 10-Q
Revenue—
Net Income$6.34M$6.34M+1,284.3% vs Q1 2025 EPS Diluted$5.01$5.01+255.3% vs Q1 2025 Operating Income-$3,618,000N/M Operating Cash Flow-$3,466,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 20, 2026 · 50 d after period end